Log in to save to my catalogue

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN C...

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN C...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_4158_EP161323_OR

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION

About this item

Full title

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION

Publisher

United States

Journal title

Endocrine practice, 2017-03, Vol.23 (3), p.258-265

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

To determine if reduction in serum insulin with dapagliflozin plus saxagliptin or dapagliflozin add-on to metformin contributed to increased insulin clearance and to assess the effects of these treatments on β-cell function.
Patients (glycated hemoglobin, 8 to 12%; 64 to 108 mmol/mol) were randomized to 24-week, double-blind treatment with saxag...

Alternative Titles

Full title

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_4158_EP161323_OR

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_4158_EP161323_OR

Other Identifiers

ISSN

1530-891X

DOI

10.4158/EP161323.OR

How to access this item